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rofessional and scientific associations that represent health care disciplines have 
a tremendous opportunity to help shape how evidence-based practice becomes 
integrated into the fabric of the professions that they support. Associations are 
membership organizations that are typically not-for-profit entities. Although their func-
tions vary, common ways in which associations can bring value to a discipline include 
(a) advocating; (b) setting and enforcing ethical standards; (c) credentialing individu-
als; (d) accrediting academic training programs; (e) providing continuing education
opportunities; (f) communicating news and other information through websites, mag-
azines, blogs, and other social media; (g) publishing scientific journals; and (h) provid-
ing other forms of professional and scientific support to their membership. For associ-
ations whose members work in the health care sector, decisions made now about how
best to plan and prioritize resources for the changing landscape in health care will
likely play a critical role in determining how well these disciplines fare over the next
decade. Actions taken by associations can affect the rate at which evidence becomes
adopted into practice and, likely, the extent to which these practice changes result in
improved patient outcomes. The nature of the efforts that are being marshaled by pro-
fessional and scientific associations to “bridge the research-to-practice gap” are numer-
ous, but perhaps the most promising among these are efforts that make use of big data,
especially when coupled with text and data mining (TDM), semantic computing, and
artificial intelligence. In this article, the need for and potential application of these tech-
nologies to advance evidence-based practice and health care quality will be de-
scribed—as well as some of the more persistent and prevalent associated challenges in
the adoption and implementation of evidence-based clinical practices.
The data-driven health care, value-based 
purchasing, and pay-for-performance trends 
in health care, as well as similar trends 
in other sectors such as K–12 education, 
have given rise to many challenges that 
require strategically focused plans of ac-
tion. Actions taken or not taken by pro-
fessional and scientific associations over
P 
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the next few years may have far-reaching 
effects on the state and health of the dis-
ciplines that they support—and, taken to-
gether, the future quality of health care. 
Although there are undoubtedly many 
paths that could help health care disci-
plines and others to transition success-
fully into becoming more data driven and 
evidence based, inaction is not likely to be 
one of those paths. Arguably, a “we’ll do 
what we’ve always done in the ways 
we’ve always done it” response is not a 
wise approach in positioning a discipline 
to survive, and potentially thrive, in the 
context of radically new economic mod-
els of health care and education right at 
our doorsteps. In health care, the daunt-
ing complexity of the transition to value-
based purchasing coupled with the 
abounding political uncertainty sur-
rounding the Affordable Care Act (ACA), 
as well as numerous other policy and reg-
ulatory uncertainties, has made it very 
difficult to plan and act. However, the 
rapid development and adoption of web 
and computing technologies have made 
the range of possibilities for action 
broader than ever before—and the poten-
tial for success greater than ever before. 
Drivers of Change for Associations 
Focused on Health Care 
 Over approximately the past 75 
years, three areas have been evolving that 
have had formative effects on the priori-
ties of the American Speech-Language-
Hearing Association. The first is the evi-
dence-based practice and implementa-
tion science movements, which encom-
pass a host of efforts aimed at improving 
the quality of the scientific evidence, the 
rate of knowledge translation, and the ef-
fectiveness of clinical practice. Under the 
umbrella of evidence-based prac-
tice/medicine, many standards and 
guidelines have been established to im-
prove the design, conduct, and reporting 
of clinical trials and to reduce bias at 
every stage of the scientific process, in-
cluding in the development of clinical 
practice guidelines. With the emergence 
of dissemination and implementation sci-
ence, a new generation of research is be-
ing conducted to bridge the research-to-
practice gap.  
The second area of rapid change is 
health care—with specific attention given 
to the central role that outcomes meas-
urement is playing in shifting to a value-
based purchasing economy. According to 
Porter and colleagues (2012), “if nations 
place outcome measurement at the top of 
their reform agendas, they can begin to 
unlock forces of innovation and improve-
ment that may yet help us realize the 
dream of financially sustainable, high-
quality health care.” Their argument, 
from a business perspective, is that health 
care in the United States has never bene-
fited from the forces of market competi-
tion because data has not been suffi-
ciently available to allow comparisons of 
providers, facilities, or systems. To shift 
successfully to a value-based purchasing 
health care economy, outcome measure-
ment needs to be mandated and the data 
made publically available. This vision 
has prompted many efforts to develop 
outcome measures and other quality in-
dicators. It has also prompted recognition 
of the need to develop clinical data regis-
tries and a host of associated supporting 
efforts—such as determining which pa-
tient characteristics are most important to 
capture—so that data can be adjusted to 
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enable valid comparisons across provid-
ers, facilities, and systems, despite the 
heterogeneity of their patient popula-
tions and facility types. 
The third evolution is big data and 
data science, an area that is redefining sci-
entific publishing, boosting the scientific 
contribution of clinical data registries and 
electronic health records, and fueling the 
data-sharing revolution. A detailed ac-
count of the sources of these trends in ev-
idence-based practice, health care, and 
big data is beyond the scope of this arti-
cle. However, a discussion of some of the 
key thought leaders and drivers of 
change is included, as their contribution 
helps tell the story of how one scientific 
and professional association, the Ameri-
can Speech-Language-Hearing Associa-
tion, is readying itself for the future. 
From across a broad mix of disciplines—
such as epidemiology, business, com-
puter science, medicine, social science, 
statistics, and more—many individuals 
and ideas have contributed to the afore-
mentioned drivers of change. However, 
in our quest to improve the human con-
dition through informed decision making 
based on trustworthy evidence, perhaps 
the largest game-changer will be the data 
itself as a contributing form of intelli-
gence. 
Historical Roots of Evidence-Based 
Practice and Data-Driven Outcomes Im-
provement 
In the Introduction to his seminal 
monograph, Effectiveness and Efficiency: 
Random Reflections on Health Service 
(1972), Archibald Cochrane confessed 
that he long held the belief that “all effec-
tive treatments must be free” (p. 3). In 
fact, he stated that he originally wrote 
that slogan to be displayed on a banner at 
a rally that he attended when the idea of 
a National Health Service (NHS) in Great 
Britain was being debated. During his 
years as a physician and a prisoner of war 
(POW), he observed that a large number 
of POWs with serious, life-threatening 
conditions survived incarceration with-
out having received medical care. This 
observation and his experiences in epide-
miology led him to the conviction that we 
need to be able to measure, without bias, 
the effects of any particular medical ac-
tion on altering the natural course of 
health conditions. He termed this type of 
knowledge “effectiveness,” and his work 
led to the preeminence of the randomized 
controlled trial for establishing the effi-
cacy of a clinical intervention. He also 
saw the necessity of being able to account 
for the costs of management, personnel 
and materials, and length of stay, among 
other things, to conduct realistic cost/ben-
efit analyses of care. He termed this di-
mension “efficiency.” His experiences 
with the inequities of health care associ-
ated with poverty led him to herald an-
other “E”—“equality”—which he de-
clared as the third “yardstick” by which 
the success of the NHS should be meas-
ured. These terms have served as a com-
pass ever since, guiding the evolution of 
health care policy, health care systems, 
analytic frameworks, and measure devel-
opment in many countries—and they 
continue to guide discussions about how 
to improve health care quality in the 
United States. As one prominent example 
of this legacy, the terms effective, efficient, 
and equitable are now three of the six di-
mensions that the Institute of Medicine 
(2011a) recommends as principles to 
guide quality improvement efforts in 
health care and that the Agency for 
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Healthcare Research and Quality 
(AHRQ, n.d.) endorses as the analytic 
framework for quality assessment in 
health care. (The other three domains are 
safe, patient-centered, and timely.)  
As these six quality domains became 
a cornerstone for assessing the return on 
investment for health care expenditures 
in the United States, organizations such 
as The Commonwealth Fund began to 
monitor health care quality across eco-
nomically comparable nations. The Com-
monwealth Fund supports independent 
research that compares health care qual-
ity and expenditures across high-income 
countries. In the most recent report, Mir-
ror, Mirror 2017: International Comparison 
Reflects Flaws and Opportunities for Better 
U.S. Health Care, 72 indicators designed to 
measure performance across five do-
mains—Care Process, Access, Adminis-
trative Efficiency, Equity, and Health 
Care Outcomes—were compared across 
11 high-income nations. As has been con-
sistently the case, the United States 
ranked lowest with respect to overall 
quality and ranked poorest in three of the 
five domains—namely, Access, Equity, 
and Health Care Outcomes. Further-
more, the report stated that “the United 
States has the highest rate of mortality 
amenable to health care and has experi-
enced the smallest reduction in that 
measure during the past decade” (p. 3). 
Of the 11 high-income nations included 
in the study, the United States is the only 
country lacking universal health insur-
ance coverage. Including both private 
and public expenditures on health care, 
the United States spends nearly 17% of its 
gross domestic product (GDP) on health 
care. The country with the next highest 
percent of GDP spent on health care was 
Switzerland (11.4%), and Australia spent 
the least (8.8%) of the 11 countries in-
cluded in the comparison. According to 
another 2017 report from The Common-
wealth Fund, Aiming Higher: Results from 
a Scorecard on State Health System Perfor-
mance, “nearly all state health systems 
improved on a broad array of health indi-
cators between 2013 and 2015. During 
this period, which coincides with the im-
plementation of the ACA’s major cover-
age expansions, uninsured rates dropped 
and more people were able to access 
needed care, particularly those in states 
that expanded their Medicaid programs” 
(p. 3). Thus, despite the current political 
uncertainties regarding the fate of the 
ACA, as of October 2017 its implementa-
tion has been associated with significant 
improvements in the quality of and ac-
cess to health care in the United States. 
That these authoritative data are not cur-
rently having a more influential effect on 
the policy makers who aim to dismantle 
the ACA—let alone on the millions of 
voters who stand to gain (or lose) so 
much pending the outcome of this de-
bate—is a puzzling, yet somewhat pre-
dictable, phenomenon. It has become a 
common observation across many sectors 
that, even in situations where there is a 
strong body of compelling scientific evi-
dence, behavior and attitudes do not nec-
essarily change accordingly—and if they 
do, it is quite likely that the rate of such 
change will be slow and will spread only 
incrementally throughout a population. 
In 1962, Everett Rogers published the 
first edition of his first book, Diffusion of 
Innovations, and coined this term to de-
scribe similar phenomena wherein new 
technologies, products, scientific find-
ings, or other innovations are gradually 
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adopted by a population. As a doctoral 
student studying rural agricultural soci-
ety at Iowa State University in the 1950s, 
Rogers became interested in modeling 
the usage patterns and rate at which Io-
wan farmers were adopting a new weed 
spray. The diffusion of innovations theory is 
broad enough to model how new ideas, 
products, scientific findings, and other 
innovations gain momentum and spread 
through a population or social system—
or fail to catch on at all. In the theory, 
Rogers describes five different categories 
of adopters—innovators, early adopters, 
early majority, late majority, and lag-
gards—and hypothesizes that the strate-
gies most likely to promote adoption will 
vary based on the adopter category. In 
the fifth edition of his book in 2003, he put 
forth the innovation-decision process 
model and proposed five factors that 
shape the rate and likelihood of adop-
tion—relative advantage, compatibility, 
complexity, trialability, and observabil-
ity. His social science theory has been ap-
plied in many other fields—including 
communications, criminal justice, mar-
keting, public health, and social work—
and it has been particularly influential in 
dissemination and implementation sci-
ence.  
In 1984, Prochaska and DiClemente 
proposed the transtheoretical model of 
change, which expands on Everett’s 
model of adoption to account for why 
people cease behaviors (or not). The slow 
rate at which Americans were ceasing to 
smoke cigarettes by the 1980s was unan-
ticipated given the large body of convinc-
ing medical research linking smoking be-
havior to cancer and the omnipresence of 
antismoking campaigns. Prochaska and 
DiClemente were motivated to under-
stand what led to the success of some 
people and yet the failure of others in 
smoking cessation. Their research led 
them to develop a six-stage model of 
change through which individuals, or so-
cial groups, might progress: precontem-
plation, contemplation, preparation, ac-
tion, maintenance, and termination. The 
notion of readiness for change is inherent 
in this model in that the actions associ-
ated with changing one’s behavior are 
unlikely to occur if the person has not yet 
contemplated and prepared for the 
change.  
Other theories of change that model 
the effects of the social environment and 
interpersonal influences also contribute 
to our understanding of how provider 
behaviors and attitudes might be influ-
enced to promote the adoption of evi-
dence-based practices. For example, con-
sider two prominent theories highlight-
ing the role that peer influence plays on 
individual decision making and behav-
ioral change—the social norms theory de-
veloped by Perkins and Berkowitz (1986), 
which was developed to understand and 
reduce alcohol consumption and alcohol-
related injury on college campuses, and 
the social network theory developed by 
Wasserman and Faust (1994). Social net-
work approaches to changing behavior 
are showing promise as an effective way 
to help clinical providers consume clini-
cal research and adopt evidence-based 
practices. Models of change may be help-
ful to advance our understanding of why 
the mere publication of scientific 
knowledge does not automatically or 
quickly result in behavioral and attitudi-
nal change, regardless of whether the tar-
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geted change entails adopting, stopping, 
or preventing behavior. These models 
may also be helpful in identifying suc-
cessful strategies for bridging the re-
search-to-practice gap. 
The Emerging Science of Dissemi-
nation and Implementation 
Identifying the factors that influence 
the diffusion of innovations in science 
and medicine to practice and policy is a 
growing focus of research often referred 
to as dissemination and implementation sci-
ence. This research seeks to narrow the 
gap between the discovery of new 
knowledge and its application by identi-
fying the factors that influence the pat-
tern and rate of change—and, ultimately, 
the maintenance of that change in people 
or systems. Estimates of the length of 
time that it takes for research to become 
translated into evidence-based policies, 
programs, and practices hovers between 
15 and 20 years. For example, Morris, 
Wooding, and Grant (2011) reviewed the 
literature that attempts to quantify the 
time lag in the health research translation 
process. The title of their article sums up 
their findings: “The Answer Is 17 Years, 
What Is the Question: Understanding 
Time Lags in Translational Research.” 
They modeled the stages from innovation 
at the basic science stage, to testing with 
human/clinical trials, to guidelines devel-
opment, to adoption in clinical practice—
a process that took an average of 17 years 
based on the literature that they re-
viewed. Their findings are similar to the 
lag time reported in other dissemination 
and implementation research (see, e.g., 
Wolff, 2008). For both humane and eco-
nomic reasons, Morris and colleagues 
(2011) argue the importance of speeding
up this process, and there is now an 
emerging consensus that evidence-based 
practices need to be more rapidly inte-
grated into clinical care. However, trans-
lating science into clinical application is 
proving to be a very challenging process; 
the reality that failure is perhaps more 
common than success has led to compar-
ing the bench-to-bedside translation pro-
cess to crossing the “valley of death” 
(Meslin, Blasimme, & Cambon-Thomsen, 
2013, p. 1).  
From the inception of a research ques-
tion to its dissemination and implemen-
tation stages, understanding the strate-
gies and factors that can promote or hin-
der the uptake of new knowledge has be-
come a central focus in health research. 
For example, in 1995, Andrew Oxman 
and colleagues published an article in 
which, once again, the title conveys the 
findings—No Magic Bullets: A Systematic 
Review of 102 Trials of Interventions to Im-
prove Professional Practice. They searched 
the literature for studies that examined 
the effectiveness of dissemination and 
implementation strategies on changing 
behavior among health care providers. 
To be included in their analysis, the study 
had to report the outcomes of the imple-
mentation “intervention” using objective 
assessments of provider performance in 
the health care setting. The intervention 
types included educational materials, 
conferences, outreach visits, presenta-
tions by local opinion leaders, audit and 
feedback, reminders, marketing materi-
als, local consensus processes, and more. 
They observed that “interventions to im-
prove professional performance are com-
plex” (p. 1427) and that complex interac-
tions likely occur among “the characteris-
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tics of the targeted professionals, the in-
terventions studied, the targeted behav-
ior, and the study design” (p. 1427). Alt-
hough no one approach stood out as a 
clear front-runner (i.e., there was “no 
magic bullet”), they concluded that using 
a combination of dissemination ap-
proaches—perhaps the most important 
of which include social learning opportu-
nities (e.g., journal groups)—“could lead 
to substantial improvements in clinical 
care derived from the best available evi-
dence” (p. 1427). To achieve the goal that 
Cochrane (1972) originally inspired of 
better health through informed decisions 
based on trusted evidence, we will need 
to understand why, as Colditz (2012) put 
it, “discovery alone does not lead to use 
of knowledge; evidence of impact does 
not lead to uptake of new strategies; or-
ganizations often do not support the cul-
ture of evidence-based practice; and 
maintenance of change is often over-
looked, leading to regression of system-
level changes back to prior state” (p. 7).  
Over the past three decades, quality 
metrics concerning the design, conduct, 
and reporting of clinical trials, evidence 
syntheses, and clinical practice guide-
lines have been developed. The unwaver-
ing aim of these metrics has been (a) to 
decrease the risk of bias and (b) to better 
ensure that research is reported and, ide-
ally, conducted to maximize its useful-
ness for replication efforts and evidence 
syntheses. For the most part, the scientific 
community is welcoming the emergence 
of standardized reporting guidelines be-
1 The UK EQUATOR Centre is hosted by the Cen-
tre for Statistics in Medicine, Nuffield Depart-
cause stakeholders are recognizing that 
many of the key details needed for devel-
oping systematic reviews and conducting 
replication studies are not routinely re-
ported in the clinical research literature 
(see, e.g., Hoffman, Chrissy, & Glaziou, 
2013). As can be seen on the EQUATOR 
Network1 website (http://www.equator-
network.org/), more than 400 reporting 
guidelines have been developed for 
many types of clinical research, including 
randomized controlled trials (e.g., Consol-
idated Standards of Reporting Trials (CON-
SORT) – http://www.consort-state-
ment.org/) as well as for the development 
of evidence-based systematic reviews 
(e.g., Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) 
– http://www.prisma-statement.org/);
and evidence-based clinical practice
guidelines (e.g., Appraisal of Guidelines for
Research and Evaluation (AGREE) –
http://www.agreetrust.org/). With these
developments, a level of consistency and
rigor has been introduced that furthers
the objectivity and value of the scientific
process—an outcome that benefits re-
searchers, students, journal publishers,
editors, reviewers, health care providers,
and, most important, patients. To fulfill
the promise of evidence-based practice,
however, there continues to be a dire
need to increase the relevance of clinical
research, the quality of scientific report-
ing, the readiness of providers, and the
capacity of health care systems to support
the implementation of evidence-based
practices.
ment of Orthopaedics, Rheumatology and Mus-
culoskeletal Sciences (NDORMS), University of 
Oxford. 
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A key component of translating re-
search to practice has been the develop-
ment of evidence-based clinical practice 
guidelines. There are numerous defini-
tions and uses of the term guidelines, in-
cluding consensus guidelines, clinical 
guidance, quality statements and stand-
ards, clinical pathways, and evidence-
based clinical practice guidelines. For 
most of the 20th century, practice guide-
lines were developed by professional so-
cieties, including the American Speech-
Language-Hearing Association, based on 
the expert opinions of a selected subset of 
members. As payers became involved, 
they began to look to guidelines as a basis 
for making coverage decisions. Once 
payers themselves got into the guidelines 
business, those that they developed had 
unrealistically high evidence standards 
that generally could not be met. Many 
feared that payer-developed guidelines 
would be used mainly to absolve payers 
of the responsibility to cover all interven-
tions except those that were most thor-
oughly researched and validated. The 
disconnect between guidelines devel-
oped by professional societies versus 
those developed by payers made it clear 
that a set of standards for guidelines de-
velopment and quality appraisal was 
needed so that the same methods and 
quality standards could be applied re-
gardless of the sponsoring entity. Ac-
cording to the Institute of Medicine (1990, 
p. 1), in 1989, Congress amended the Pub-
lic Health Service Act to create the
Agency for Healthcare Research and
Quality (AHRQ; originally called the
Agency for Health Care Policy and Re-
search), largely to address this discon-
nect. Under the terms of Public Law 101-
239, AHRQ “has broad responsibilities 
for supporting research, data develop-
ment, and other activities that will en-
hance the quality, appropriateness, and 
effectiveness of health care services. The 
creation of a practice guidelines function 
within [AHRQ] can be seen as part of a 
significant cultural shift, a move away 
from unexamined reliance on profes-
sional judgment toward more structured 
support and accountability for such judg-
ment. Reflecting the first element of this 
shift, guidelines are intended to assist 
practitioners and patients in making 
health care decisions; reflecting the sec-
ond aspect, they are to serve as a founda-
tion for instruments to evaluate practi-
tioner and health system performance” 
(p. 2-3).  
In 2003, the era of consensus-based 
guidelines began a steady decline as the 
AGREE instrument for evaluating the 
process of practice guideline develop-
ment and the quality of reporting was 
born. The Institute of Medicine (2011a) 
defined clinical practice guidelines as 
“statements that include recommenda-
tions, intended to optimize patient care, 
that are informed by a systematic review 
of evidence and an assessment of the ben-
efits and harms of alternative care op-
tions” (p. 1). A variety of stakeholders 
have used different methods to develop 
guidelines across different organizations 
and countries, but the Scottish Intercolle-
giate Guidelines Network (SIGN), the 
National Institute of Clinical Excellence 
(NICE), and Guidelines International 
(GIN) are the primary entities setting 
standards and providing tools for devel-
oping evidence-based clinical practice 
guidelines. As mentioned above, AGREE 
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is the most widely accepted set of stand-
ards by which the quality of clinical prac-
tice guidelines is evaluated. In addition, 
developers of clinical practice guidelines 
often use the Grading of Recommenda-
tions Assessment, Development and 
Evaluation (GRADE) approach to de-
velop recommendations based primarily 
on findings from evidence-based system-
atic reviews (http://www.gradeworking-
group.org/). The purpose of GRADE is to 
evaluate the quality of evidence and the 
strength of the proposed recommenda-
tions in a clinical practice guideline. 
GRADE uses five criteria to evaluate the 
quality of evidence: risk of bias, con-
sistency of evidence, directness of evi-
dence, precision in results, and publica-
tion bias. Based on these criteria, the 
overall quality of evidence is ranked and 
categorized into four levels. According to 
Langhoff-Roos and Shah (2016), the key 
concept behind the strength of recom-
mendation in the GRADE approach is 
“the extent to which one can be confident 
that the desirable consequences of an in-
tervention outweigh its undesirable con-
sequences” (p. 844). All of the efforts that 
have been devoted to establishing quality 
standards for clinical research methodol-
ogy, for reporting clinical research, for 
developing evidence-based systematic 
reviews, and for creating evidence-based 
clinical practice guidelines are moving us 
closer to bridging the research-to-practice 
gap. Unfortunately, the relevance of 
much of the biomedical and behavioral 
sciences research with respect to its ap-
plicability to clinical practice continues to 
be a very challenging shortcoming (Col-
ditz, 2012). 
The Promise of Clinical Data Regis-
tries as Learning Health Care Systems 
Clinical data registries hold much 
promise to fill in some of the gaps left un-
addressed in the extant body of clinical 
research that has been initiated by indi-
vidual scientists or teams of investiga-
tors. That investigator-initiated research 
may leave knowledge gaps is not surpris-
ing. Researchers necessarily focus deeply 
on specific topics and, understandably, 
may give less attention to how their re-
search may be implemented in clinical 
practice or used to influence policy. Even 
for interventions whose effectiveness has 
been established with randomized con-
trolled trials, typically little will be 
known about how well the intervention 
will work when applied to a wider range 
of patients and different settings than 
those included in controlled studies. 
Clinical data registries may help to fill in 
gaps in the body of investigator-initiated 
research. Moreover, because clinical data 
registries and electronic health records 
accumulate large samples of heterogene-
ous patient populations, there are ques-
tions that are arguably best addressed 
through big data and data science. Infor-
mation about patient characteristics, the 
interventions applied, the outcomes of 
care, and the resources utilized can be 
amassed in clinical registries and ana-
lyzed to address the multifaceted ques-
tion of “What works best for whom un-
der which circumstances?” (see, e.g., 
Paul, 1967). This concept is described by 
the Institute of Medicine’s Learning Health 
System Series (2011b). The report states 
that “health and health care are going 
digital. As multiple intersecting platforms 
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evolve to form a novel operational 
foundation for health and health care—
the nation’s digital health utility—the 
stage is set for fundamental and unprece-
dented transformation. Most changes 
will occur virtually out of sight, and the 
pace and profile of the transformation 
will be determined by the stewardship 
that fosters alignment of technology, sci-
ence, and culture in support of a continu-
ously learning health system. In the con-
text of growing concerns about the qual-
ity and costs of care, the nation’s health 
and economic security are interde-
pendently linked to the success of that 
stewardship. Progress in computational 
science, information technology, and bio-
medical and health research methods 
have made it possible to foresee the emer-
gence of a learning health system that en-
ables seamless and efficient health deliv-
ery of best care practices and the real-
time generation and application of new 
knowledge. Increases in the cost and 
complexity of care compel such a system” 
(p. 1). 
Central to the goals of cost contain-
ment and budgeting health care expendi-
tures is the ability to predict that, based 
on the incidence of a given condition, a 
given number of individuals will need a 
given regiment of treatments at an esti-
mated annual cost. At a minimum, four 
data domains are needed to inform pre-
dictive models of health care expendi-
tures and to serve as a learning health 
care system, including information about 
patients (case-mix data), the services and 
interventions provided, the outcomes of 
care, and an accounting of the resources 
utilized to achieve these outcomes. Pay-
ment systems based on predictive model-
ing need first to be able to predict, based 
on historical data, the rehabilitation po-
tential of individual patients and then, 
based on evidence about which approach 
to intervention is likely to be most effec-
tive for a given type of patient in a given 
circumstance, predict the resources that 
will be required to achieve pre-specified 
rehabilitation goals. According to Massof 
(2010), the primary goal for such model-
ing is to predict the probability of obtain-
ing a specified outcome given a mix of 
patient-specific factors and the choice of 
interventions. As patient factors mediate 
the effects of services on outcomes, case-
mix–adjusted data are necessary to com-
pare the effectiveness of different inter-
ventions and to model the costs and ben-
efits of providing services for specific pa-
tient groupings.  
With clinical data registries and data 
science added to the arsenal of clinical re-
search methods, we can move beyond 
asking, “What works?” to addressing, 
“What works best for whom under which 
circumstances?” As put forth by Rogers 
and Mullen (2012), it is unlikely that we 
will be able to address this multifaceted 
question solely through investigator-ini-
tiated research. They assert that large-
scale data collection instruments that 
amass information across each of the four 
data domains mentioned above are nec-
essary so that adequately powered anal-
yses can be conducted to identify the ef-
fects that case-mix and service delivery 
factors have on patient outcomes. The vi-
sion of a learning health care system is 
that analyses of large clinical data reposi-
tories will provide information about 
what works best for whom under which 
circumstances. Based on these analyses, 
decisions will be made about how ser-
vices and outcomes might be improved. 
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After providers and systems make tar-
geted adjustments, the newly collected 
data will provide information about the 
relative success and failure of the adjust-
ments. Within the context of a learning 
health care system, data collection, anal-
ysis, change, and learning are cyclical, it-
erative stages. Learning health care sys-
tems are anticipated to accelerate the rate 
at which evidence-based practices and in-
novations in health care become adopted; 
thereby, reducing the research-to-prac-
tice gap. 
Data-Driven Publication Strategies 
for Straightening the Path to Implemen-
tation 
As noted previously, the gap between 
discovery of new knowledge and its im-
plementation can be quite large, and the 
potential barriers to implementation can 
be so varied that there is no magic bullet 
for how to infuse evidence-supported 
changes into practice across the board. 
Although the optimal path to any given 
implementation may be unclear, there are 
a number of ways that professional and 
scientific associations can leverage their 
innate strengths to increase the precision 
and efficiency of implementation strate-
gies. This is particularly true now be-
cause of the shift to a much more data-
based and data-driven journal publishing 
enterprise that has unfolded over the past 
two to three decades. 
Whereas the initial three centuries of 
journal publishing involved some struc-
tured data in the sense of the articles 
themselves having a defined, sectioned 
format and both the articles and the jour-
nals having bibliographic elements suffi-
cient for tracking and organization of the 
collection of outputs over time, it was not 
until the online publishing era that true 
structuring began to be put in place. Cov-
ering that evolution could itself fill may 
pages—and has (see, e.g., Ware & Mabe, 
2015)—but a key milestone in that evolu-
tion was the relatively recent shift to the 
article, rather than the journal, being the 
“unit.”  
In an article-based economy, the en-
tire publishing workflow changes. Rather 
than hold articles for publication until, 
say, the next quarterly issue of a clinical 
practice journal, publishers (including 
the American Speech-Language-Hearing 
Association) have increasingly adopted 
continuous publishing models so that im-
portant research can be released as soon 
as it is ready to be read and used. In prac-
tical terms, this shaves off a period of 
time, often up to several months, from the 
overall amount of time that it takes to get 
new knowledge into implementation. 
With a timeline of 17 years associated 
with implementation, every such reduc-
tion counts. 
Because of the focus on article-based 
publication, publishers have sought com-
petitive advantage in time-to-market, 
and that has led to more radical reduc-
tions in the amount of time from the re-
port of findings to the availability of that 
information in the environment where 
application of it can be made. Standardi-
zation at the XML markup level is now 
more typically relied on from submission 
all the way through to the production and 
publication of research. And it is increas-
ingly driving a shift in the authoring pro-
cess, as well. In aggregate, the standardi-
zation of the data behind the full range of 
the publication steps has certainly shaved 
off another several months to a year or 
more from the time it takes for new 
knowledge to get into discovery and use. 
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Likewise, concomitant with this now 
accelerated flow of new knowledge into 
the discovery environment, the same 
data standards underpinning its pro-
cessing and production are also driving 
the means of discovery itself. In the era of 
the issue-based publication model, mas-
sive “stacks” of information developed 
and were archived in libraries and, even-
tually, stored in online repositories and 
aggregations, both accessible through a 
search approach where success was as 
variable as the searcher’s facility with 
query construction. In the semantic pub-
lishing era, very granular tagging is ap-
plied to articles so that a publisher’s plat-
form can display articles in automatically 
curated collections by topic and can dy-
namically link related articles, thereby 
extending a user’s discovery. This, then, 
shaves additional time from the discov-
ery phase of acquiring and applying new 
knowledge, although it would be hard to 
quantify the level of reduction in any 
meaningful way, given the breadth of 
disciplines and pace of development of 
research lines. In aggregate, savings here 
may more realistically be considered a 
factor mitigating against the sheer diffi-
culty of coping with the greatly increased 
flow of new knowledge into the system, 
as made possible by the previously cov-
ered advances.  
More important, the opportunities af-
forded by semantic tagging allow the 
publisher to offer a well-organized, 
highly accessible library of information 
versus a merely browsable online collec-
tion of articles that had been produced in 
print. In the article-based economy, with 
semantic data better characterizing the 
articles and being used to drive addi-
tional pathways into the stacks and away 
from arrived-at articles to other articles 
that otherwise might not have been 
found, the deeper opportunity now exists 
for such publishers to better assess the ac-
tual patterns of knowledge acquisition or 
attempted knowledge acquisition—and 
to marry up those patterns with future 
curation and promotion activities. The 
opportunity is thus greater than ever for 
the society publisher to be a valued con-
nector in the process of bridging research 
to practice, by virtue of that central, high-
value information resource. 
In addition to semantic data and the 
opportunities presented by it, the online 
article-based economy and its prevailing 
standards related to the objects them-
selves, such as the digital object identifier 
(DOI), have driven significant advances 
in other forms of data, such as attention-
level metrics. A user can now rely on alt-
metrics, for example, to track how re-
search has been used so far and by whom. 
For a publisher, imagine the value of that 
type of multifaceted data layered onto se-
mantic usage data. Just over 10 years ago 
at the American Speech-Language-Hear-
ing Association, for comparison pur-
poses, virtually none of that data existed. 
Issues were produced and shelved at li-
braries or physically placed in mailboxes, 
and citation data years down the line 
were the only approximate gauge of how 
published research was being used.  
This is truly the revolutionary point 
at which the gap between output (re-
search) and use (practice) can begin to be 
more effectively observed and appraised. 
On the near-term horizon (and, in some 
cases, already in place) are advances such 
as text and data mining layers in publish-
ing platforms, so that automated analyses 
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of the nature of patterns of research (in-
cluding populations addressed, tech-
niques used, and types of data derived) 
can be performed vastly more quickly 
and precisely. In addition, systems 
providing predictive analytics on citation 
likelihood are now being put into place. 
At the user level, the now more com-
monly in place HTML5 web standards 
are allowing for greater annotation of 
content and incorporation of it into 
shared learning activities.  
All of these advances are emblematic 
of the tide of big data flooding all pub-
lishers. For the society publisher, deriv-
ing intelligence from that flow and lever-
aging it alongside programmatic efforts 
aimed at bridging the research-to-prac-
tice gap amounts to a fundamentally dif-
ferent business than what scholarly pub-
lishing formerly offered an association. 
The publishing enterprise within associa-
tions must be retooled accordingly, with 
a greater emphasis placed on strategizing 
with editors, working more directly with 
authors, and focusing on different do-
mains—away from day-to-day produc-
tion and toward a fuller embrace of sci-
ence writing, content curation, and well-
developed curation and promotion skills, 
especially those focused on support of 
learning-based usage contexts. If the past 
two decades have been any guide, the 
next two should lead to measurable im-
provements in reducing the gap from re-
search to practice. 
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